Jeffrey Riley
Direttore/Membro del Consiglio presso GAIN THERAPEUTICS, INC.
Patrimonio netto: 76 500 $ in data 31/05/2024
Profilo
Jeffrey Lucero Riley is the founder of 526 Ventures LLC, which was founded in 2009.
He held the title of Partner from 2009 to 2012.
He is currently the Chief Executive Officer & Director at BlinkTBI, Inc. since 2020, Chief Executive Officer & Director at CaraVan Biologix since 2021, Managing Director at Black Crow Ventures LLC since 2009, Independent Director at GT Gain Therapeutics SA since 2019, and Independent Director at Gain Therapeutics, Inc. since 2019.
In his former positions, he was the President, Chief Executive Officer & Director at Theriva Biologics, Inc. from 2012 to 2017, Chief Financial Officer & VP-Corporate Development at Nichols Institute Diagnostics, Vice President-Finance & Corporate Development at Amphora Discovery Corp.
from 2009 to 2010, President at Telesso Technologies Ltd.
in 2009, and Venture Partner at Queensland BioCapital Funds Pty Ltd.
He completed his undergraduate degree at Boise State University and holds an MBA from Thunderbird School of Global Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
GAIN THERAPEUTICS, INC.
0.17% | 24/06/2024 | 30 000 ( 0.17% ) | 76 500 $ | 31/05/2024 |
Posizioni attive di Jeffrey Riley
| Società | Posizione | Inizio |
|---|---|---|
| GAIN THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/05/2019 |
| Black Crow Ventures LLC | Corporate Officer/Principal | 01/11/2009 |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Direttore/Membro del Consiglio | 11/09/2019 |
BlinkTBI, Inc.
 BlinkTBI, Inc. Data Processing ServicesTechnology Services Blinktbi, Inc. engages in the development of a eye test technology that provides objective data about neurological function to support medical personnel. The company was is headquartered in Charleston, SC. | Amministratore Delegato | 27/08/2020 |
| CaraVan Biologix | Direttore/Membro del Consiglio | 01/09/2021 |
Precedenti posizioni note di Jeffrey Riley
| Società | Posizione | Fine |
|---|---|---|
| THERIVA BIOLOGICS, INC. | Amministratore Delegato | 05/12/2017 |
| 526 Ventures LLC | Fondatore | 01/01/2012 |
Amphora Discovery Corp.
 Amphora Discovery Corp. Pharmaceuticals: MajorHealth Technology Amphora Discovery Corp. develops and manufactures pharmaceutical products. It provides custom assay development and enzymology services. The company provides drug discovery contract research services, HTS, profiling and lead generation services. The company was founded in September 2001 and is headquartered in Durham, NC. | Direttore Finanziario/CFO | 24/03/2010 |
| TELESSO TECHNOLOGIES LTD. | Presidente | 30/06/2009 |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Jeffrey Riley
| Thunderbird School of Global Management | Masters Business Admin |
| Boise State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| THERIVA BIOLOGICS, INC. | Health Technology |
| GAIN THERAPEUTICS, INC. | Health Technology |
| Aziende private | 9 |
|---|---|
Nichols Institute Diagnostics
 Nichols Institute Diagnostics Medical/Nursing ServicesHealth Services Nichols Institute Diagnostics engages in manufacturing and marketing immunoassay systems utilizing direct label chemiluminescence and immunoradiometric technology. The company is headquartered in San Clemente, CA. | Health Services |
Amphora Discovery Corp.
Amphora Discovery Corp. Pharmaceuticals: MajorHealth Technology Amphora Discovery Corp. develops and manufactures pharmaceutical products. It provides custom assay development and enzymology services. The company provides drug discovery contract research services, HTS, profiling and lead generation services. The company was founded in September 2001 and is headquartered in Durham, NC. | Health Technology |
Telesso Technologies Ltd.
 Telesso Technologies Ltd. Pharmaceuticals: OtherHealth Technology Telesso Technologies Ltd. was engaged in biotechnology research and development. The company was founded on December 15, 1995 and was headquartered in Melbourne, Australia. | Health Technology |
Queensland BioCapital Funds Pty Ltd.
 Queensland BioCapital Funds Pty Ltd. Investment ManagersFinance Queensland BioCapital Funds Pty Ltd. (QBF) is the venture capital arm of Queensland Investment Corporation, a Queensland Government-owned corporation. QBF established in 2002, located in Australia. | Finance |
| Black Crow Ventures LLC | |
| 526 Ventures LLC | |
BlinkTBI, Inc.
BlinkTBI, Inc. Data Processing ServicesTechnology Services Blinktbi, Inc. engages in the development of a eye test technology that provides objective data about neurological function to support medical personnel. The company was is headquartered in Charleston, SC. | Technology Services |
GT Gain Therapeutics SA
GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Health Technology |
| CaraVan Biologix |
- Borsa valori
- Insiders
- Jeffrey Riley
